• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Port Info

• Ships in Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

The Canadian operations is completely sales and marketing oriented, and is part of the company's strategy to expand overseas.

The Minister of State for Science and Technology, Mr Kapil Sibal (left), with Mr Malvinder Mohan Singh, President, Pharmaceuticals, Ranbaxy Laboratories Ltd, and the Canadian International Trade Minister, Mr James S. Peterson, at the Indo-Canadian Technology Summit in the Capital on Wednesday. — Kamal Narang

New Delhi , Sept 21

RANBAXY Laboratories Ltd is expanding its geographical presence to Canada by setting up a wholly owned subsidiary in that market.

Along with this, the company also hopes to launch its new anti-malaria drug in the next 3-4 years.

Speaking to newspersons on the sidelines of the CII Technology Summit, Mr Malvinder Mohan Singh, President (Pharmaceuticals), Ranbaxy, said: "Currently, we are conducting Phase-II clinical trials for a new chemical entity for malaria and if everything goes well, we expect the product to hit the market by 2008-09."

The research for the new anti-malaria drug is being conducted in collaboration with Medicines Malaria Venture, Geneva.

The clinical trials for the new molecule is being conducted in three countries and the company hopes that the drug will have a large market not only in India but in other developing countries of southern Africa and South-East Asia.

Ranbaxy is planning to commence its Canadian operations tomorrow, where it will look at marketing its generic products portfolio and drugs that are about to go off-patent.

The Canadian operation is completely sales and marketing oriented, and is part of the company's strategy to expand overseas since Canada is the eighth largest pharma market in the world.

Addressing the conference, Mr Singh said that the company has been at the forefront of providing cheap anti-AIDS drugs to countries around the world.

The recent US FDA approvals for its anti-retrovirals would be yet another step in this direction.

Earlier, Mr Jim Peterson, International Trade Minister of Canada, announced a $6.75-million package for collaborative research between Canadian and Indian scientists for the next five years.

"Not only will this funding help advance Canadian research and development, it will enhance our commercial relations with India and give our companies the edge in their sectors of expertise," he added.

The Minister for Science and Technology, Mr Kapil Sibal, said that the Indian Government too was open to research collaborations and proposed the setting up of a nanotechnology research centre.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
L&T bags Rs 430-cr orders for export of process plant equipment

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line